Clinical Trials Browser

Phase 1/2 × Isosorbide × Gastrointestinal × Clear all

NCT07456852 2026-03-09

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Phase 1/2 Not yet recruiting

Gastrointestinal

Gastrointestinal Neoplasms